Cutter & Co Brokerage’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,407
| Closed | -$4.08M | – | 169 |
|
|
2025
Q1 | $4.08M | Sell |
8,407
-3,355
| -29% | -$1.63M | 0.96% | 27 |
|
|
2024
Q4 | $4.74M | Buy |
11,762
+220
| +2% | +$88.6K | 1.16% | 22 |
|
|
2024
Q3 | $5.37M | Sell |
11,542
-192
| -2% | -$89.3K | 1.21% | 20 |
|
|
2024
Q2 | $5.5M | Sell |
11,734
-174
| -1% | -$81.6K | 1.33% | 15 |
|
|
2024
Q1 | $4.98M | Buy |
11,908
+116
| +1% | +$48.5K | 1.22% | 19 |
|
|
2023
Q4 | $4.8M | Sell |
11,792
-209
| -2% | -$85K | 1.33% | 15 |
|
|
2023
Q3 | $4.17M | Sell |
12,001
-109
| -0.9% | -$37.9K | 1.22% | 16 |
|
|
2023
Q2 | $4.26M | Buy |
12,110
+75
| +0.6% | +$26.4K | 1.26% | 16 |
|
|
2023
Q1 | $3.79M | Sell |
12,035
-141
| -1% | -$44.4K | 1.18% | 16 |
|
|
2022
Q4 | $3.52M | Sell |
12,176
-112
| -0.9% | -$32.3K | 1.19% | 19 |
|
|
2022
Q3 | $3.56M | Sell |
12,288
-45
| -0.4% | -$13K | 1.32% | 15 |
|
|
2022
Q2 | $3.48M | Sell |
12,333
-935
| -7% | -$263K | 1.19% | 21 |
|
|
2022
Q1 | $3.46M | Buy |
13,268
+838
| +7% | +$219K | 1.03% | 27 |
|
|
2021
Q4 | $2.73M | Buy |
12,430
+310
| +3% | +$68.1K | 0.75% | 38 |
|
|
2021
Q3 | $2.2M | Buy |
12,120
+225
| +2% | +$40.8K | 0.52% | 61 |
|
|
2021
Q2 | $2.4M | Buy |
11,895
+1,050
| +10% | +$212K | 0.55% | 59 |
|
|
2021
Q1 | $2.33M | Buy |
10,845
+6,615
| +156% | +$1.42M | 0.57% | 57 |
|
|
2020
Q4 | $1M | Buy |
+4,230
| New | +$1M | 0.26% | 87 |
|